Delia Cuevas-Aguirre

Title: Delia Cuevas-Aguirre: Innovator in Platelet Aggregation Inhibition

Introduction

Delia Cuevas-Aguirre is a prominent inventor based in Cuernavaca, Mexico. She has made significant contributions to the field of biomedical research, particularly in the area of platelet aggregation inhibition. With a total of 2 patents to her name, her work has the potential to impact medical treatments for various conditions.

Latest Patents

Her latest patents include a groundbreaking invention titled "Collagen-induced platelet aggregation inhibitor." This invention provides a protein derived from Triatoma pallidipennis that inhibits collagen-induced platelet aggregation. The protein is particularly useful for inhibiting collagen-induced human platelet aggregation or for addressing cancer with metastatic tumor cells.

Career Highlights

Delia Cuevas-Aguirre is associated with Schering Aktiengesellschaft, a company known for its innovative pharmaceutical solutions. Her work at this organization has allowed her to focus on developing therapies that can significantly improve patient outcomes.

Collaborations

Throughout her career, Delia has collaborated with notable colleagues, including Christiane Noeske-Jungblut and Bernard Jacques Haendler. These collaborations have further enriched her research and contributed to her success as an inventor.

Conclusion

Delia Cuevas-Aguirre's contributions to the field of platelet aggregation inhibition highlight her innovative spirit and dedication to advancing medical science. Her patents represent a significant step forward in the development of treatments for serious health conditions.